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Abstract 
Background: Methicillin-resistance in staphylococci is conferred by the mecA gene, located on the genomic island 
Staphylococcal Cassette Chromosome mec (SCCmec). SCCmec mobility relies on the Ccr recombinases, which catalyze 
insertion and excision form the host’s chromosome. Although being a crucial step in its horizontal transfer, little is 
known about the dynamics of SCCmec excision.
Results: A quantitative PCR-based method was used to measure the rate of SCCmec excision by amplifying the 
chromosome–chromosome junction and the circularized SCCmec resulting from excision. SCCmec excision rate was 
measured in methicillin-resistant Staphylococcus aureus (MRSA) strain N315 at various growth times in broth cultures. 
In the present experimental settings, excision of SCCmec occurred at a rate of approximately 2 × 10−6 in MRSA N315.
Conclusion: This work brings new insights in the poorly understood SCCmec excision process. The results presented 
herein suggest a model in which excision occurs during a limited period of time at the early stages of growth.
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Background
Staphylococcus aureus is a successful human pathogen, 
causing a large variety of diseases that range from minor 
skin infections to life-threatening bloodstream infec-
tions and endocarditis [1]. Many of the virulence factors 
encoded by S. aureus are located within mobile genetic 
elements, which come in addition to the well-conserved 
core genome, and account for the majority of genetic 
variation between the isolates [2–4]. This is also often the 
case for antibiotic resistance genes, which can be found 
on plasmids, transposons or genomic islands [4].
Methicillin-resistant S. aureus (MRSA) arose during 
the 1960s, due to the acquisition of the Staphylococcal 
Cassette Chromosome mec (SCCmec) [5]. SCCmec is a 
staphylococcal genomic island carrying the mecA gene, 
which encodes the low affinity penicillin-binding pro-
tein 2a (PBP2a) that is responsible for cross resistance 
to virtually all antibiotics of the β-lactam family [5, 6]. 
It is inserted at a unique location in the chromosome by 
the Ccr proteins (cassette chromosome recombinases), 
which catalyze site-specific recombination between a 3′ 
end of the rlmH gene (attB), previously known as orfX, 
and the homologous sequence on SCCmec (attS). Upon 
integration the attS and the attB sequences form two 
direct repeats (designated attL and attR) flanking the cas-
sette [7, 8]. In the opposite path, Ccr proteins catalyze the 
excision of SCCmec from the host’s chromosome [8, 9].
Early clues of SCCmec excision rate were reported by 
Ito et al., who detected excision of the cassette in MRSA 
N315 at a rate of less than 10−4 [10]. Nevertheless, pre-
cise excision rate and dynamics of SCCmec excision have 
never been determined. To address this issue, we used 
a qPCR-based system allowing us to quantify precisely 
the rate of SCCmec net excision from the chromosome 
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of MRSA strain N315, as well as to detect the resulting 
excised closed circular forms appearing in the cell.
Methods
Bacterial strains, media and culture conditions
Bacterial strains and plasmids used in this study are listed 
in Table  1. Escherichia coli strain DH5α was routinely 
used for plasmid propagation and cloning experiments, 
and cultivated on Luria-Bertani (LB) medium (Bec-
ton–Dickinson, Sparks, MD, USA) supplemented with 
100 mg/L ampicillin (AppliChem, Darmstadt, Germany) 
at 37  °C. S. aureus strains were grown with aeration in 
trypticase soy broth (TSB) (Difco Laboratories, Detroit, 
MI, USA) in a rotating incubator (at 180 rpm) at 37  °C. 
If required, tetracycline and kanamycin (AppliChem) 
were added at a final concentration of 10 mg/L. Oxacillin 
(Sigma-Aldrich, Buchs, Switzerland) was used at 4 mg/L, 
which corresponded to the MICs for strain N315.
DNA manipulations
Genomic DNA of S. aureus was extracted using a proto-
col described previously [14]. For genomic DNA, 3 mL of 
overnight cultures were harvested and resuspended in 50 
μL of lysis solution (0.5 μg/mL lysostaphin, 10 mM Tris–
Cl, pH 7.5, and 1 mM EDTA). After 30 min of incubation 
at 37 °C, cell suspension were lysed by adding 300 μL of 
“Nuclei Lysis Solution” (Promega Corporation, Madison, 
WI) and heating at 80 °C for 10 min. After RNase treat-
ment, 100 μL of “Protein Precipitation Solution” (Pro-
mega Corporation) were added to the samples, followed 
by incubation on ice for 5 min. Samples were then centri-
fuged (15,600×g) at 4  °C for 10 min. Supernatants were 
recovered and DNA was precipitated using 300 μL of iso-
propanol, followed by centrifugation (15,600×g) at 4  °C 
for 10 min. DNA precipitate was washed with 70 % etha-
nol and pelleted by centrifugation (15,600×g) at 4 °C for 
10 min. DNA samples were then air-dried and dissolved 
at 4  °C overnight in 20μL of nuclease-free H2O. DNA 
concentrations and qualities were determined using an 
ND-1000 Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE).
Plasmids from E. coli were isolated using the QIAprep 
Spin Miniprep Kit (QIAGEN Inc., Hilden, Germany). The 
same protocol was used for S. aureus, after treatment 
with lysis solution (0.5 μg/mL lysostaphin, 10 mM Tris–
Cl, pH 7.5, and 1 mM EDTA).
Digestions with restriction enzymes (Promega AG, 
Dübendorf, Switzerland) were carried out according to the 
manufacturer’s specifications. PCR fragments were puri-
fied using the QIAquick PCR Purification Kit (Qiagen Inc.) 
and gel-bands were purified using QIAquick Gel Extraction 
Kit (Qiagen Inc.) according to manufacturer’s protocols. 
Ligations were performed using 1 μL of T4 ligase (Promega 
AG) according to the manufacturer’s specifications.
PCR and quantitative PCR (qPCR)
All primers used in this study are listed in Table 2. GoTaq 
DNA polymerase (Promega AG) was used for colony 
PCR screening during cloning experiments and end-
point PCR. DNA fragments required for cloning were 
amplified with KAPA HiFi DNA Polymerase (KAPA Bio-
systems, Cape Town, South Africa). All reactions were 
carried out according to manufacturers’ specifications.
Artificial excision of SCCmec to obtain N315EX
SCCmec was cured from S. aureus N315 to obtain 
N315EX using a method from Katayama et al. [7]. Briefly, 
strain N315 was electroporated with thermosensitive 
plasmid pSR3-1, containing the ccrAB genes and a tet-
racycline-resistance marker. Transformants were grown 
for 24 h at 30 °C in TSB supplemented with tetracycline, 
serially diluted and plated on TSA supplemented with 
tetracycline. Single colonies were picked, grown for 24 h 
at 42  °C TSB to promote cure of thermosensitive pSR3-
1, and dilutions were plated on TSA to screen for colo-
nies susceptible to both oxacillin and tetracycline. One 
Table 1 Bacterial strains and plasmids
Strain or plasmid Relevant characteristics References
Strains
E. coli DH5α Host for DNA cloning Laboratory collection
S. aureus
 RN4220 Restriction-deficient derivative of S. aureus RN450 [11]
 N315 MRSA carrying type II SCCmec [12]
 N315EX Isogenic MSSA derivative of N315 This study
Plasmids
pUC28 ColE1 replicon, high copy number vector for cloning, ampicillin resistance [13]
pSR3-1 Thermosensitive-replicon plasmid carrying the ccrAB genes of strain N315 (used for SCCmec excision in 
N315), tetracycline resistance
[7]
qPlasmid Plasmid used for qPCR analysis This study
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double-susceptible colony, which lost both the plasmid 
(i.e. tetracycline-resistance) and kanamycin-resistance 
(encoded by SCCmec), was recovered and absence of 
SCCmec was confirmed by PCR amplification of qEx frag-
ment using primers pair Excision fw and rev (Table 2).
Co‑culturing of N315 and N315EX
Co-culturing assays were performed in triplicates. 103 
CFU of overnight cultures of parent MRSA N315 and its 
excisant N315EX were washed with phosphate buffered 
saline, mixed at 102 CFU/mL each in 10 mL of TSB, and 
incubated at 37  °C. The CFU counts of the two strains 
were determined by plating dilutions of the cultures at 
0, 7, 24, 48 and 72 h. Strain N315 was selected for kana-
mycin-resistance (encoded by SCCmec and more reliable 
than resistance to oxacillin) on TSA plates supplemented 
with kanamycin, and total number of cells was deter-
mined by plating the competition mixture on TSA plates. 
Quantification of strain N315EX was calculated by sub-
tracting the number of CFU on kanamycin plates from 
the number of CFU on plates without antibiotic.
Designing a qPCR‑based system to quantify site‑specific 
excision of SCCmec and formation of the circular forms
Specific primers were designed using Primer3 software 
(version 2.3.4, [15]) and used to amplify the three targets 
depicted in Fig.  1. qControl amplicon, targets a region 
of rlmH gene, which is present in cells with and without 
SCCmec. This control was used to determine the num-
ber of total chromosomes in the samples. Amplicons qEx 
and qCirc were used to specifically detect excisants and 
circularized SCCmec, respectively. These were compared 
to the total number of chromosomes, which was deter-
mined by targeting a region of the rlmH gene, present in 
both MRSA- and MSSA-like cells.
In order to standardize the qPCR assay, qPlasmid, a 
plasmid carrying the three targets of the qPCR reactions 
(qCirc, qControl, and qEx) was constructed (Fig.  1). A 
555-bp fragment containing the chromosomal junction 
formed upon excision, amplified from chromosomal DNA 
of S. aureus N315EX, was cloned in pUC28 using restric-
tions sites SphI and XbaI. A second fragment of 411 bp, 
containing the attS site from the SCCmec circular form, 
was amplified from chromosomal DNA of S. aureus N315 
and cloned using EcoRI and SphI restriction sites.
Quant-iT™ PicoGreen® dsDNA Assay Kit (Thermo 
Fisher Scientific AG, Switzerland) was used to determine 
concentration of qPlasmid, which was subsequently used 
to optimize the reactions efficiencies of qControl, qEx 
and qCirc amplicons. Different amounts of qPlasmid (40, 
4 × 102, 4 × 104, 4 × 106 and 4 × 108 copies) were used 
as template for different primer concentration combina-
tions in order to find the optimal conditions (Additional 
file 1: Supporting data 1).
qPCR reactions were performed in 20 μL volume reac-
tions using the KAPA SYBR FAST qPCR Kit (Kapa 
Table 2 Primers used in the study
a Position in the chromosome of S. aureus N315 (GenBank:BA000018)
Primer Sequence Positiona Annealing  
temperature (°C)
Screening primers
 Excision fw GTTTAGGCCCATACACCAAGATAGA 33768–33792 54.7
 Excision rev TGTCCACCATTTAACACCCTCC 87194–87173 55.1
Cloning primers
 orfXcloning fw TTTTTTGCATGCAAATCACCATTTTAGCTGTAGGG
                  Sphl
33696–33718 64.2
 orfXcloning rev TTTTTTTCTAGAATTGAATGAACGTGGATTTAATG
                      XbaI
87215–87193 57.2
 circCloning fw TTTTTTGAATTCTTGTGGAAGGTTTGAAGACTACG
                    Ec oRl
86883–86905 59.8
 circCloning rev TTTTTTGCATGCGAAAGACTGCGGAGGCTAACTAT
                      Sphl
34316–34294 66.6
qPCR primers
 qControl fw CGTTTAGGCCCATACACCAAGATAGAC 33767–33793 59.2
 qControl rev TGATACATTCAAAATCCCTTTATGAAGCG 34215–34187 60.1
 qEx fw CGCAGTAACTACGCACTATCATTCAGC 34049–34075 59.4
 qEx rev TGAATGAACGTGGATTTAATGTCCACC 87213–87187 60.8
 qCirc fw GGTTTAATTAATAGAGGAGTGGAGCCTTTGA 87037–87067 60.6
 qCirc rev CTTCTTAAAAACATAACAGCAATTCACATAAACC 34259–34226 60.1
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Biosystems). DNA samples extracted from three inde-
pendent cultures inoculated with 1  mL of overnight cul-
ture (approximately 109 CFU) in 100  mL of TSB were 
used as template for the assays. When required, oxacil-
lin was added at the concentration of 4 mg/L before add-
ing the inocula. A total of 5 ng of DNA was used for each 
analysis. Reactions were carried out in MicroAmp optical 
tubes (Applied Biosystems, Foster City CA, USA) using an 
ABI7000 machine (Applied Biosystems). The following run 
protocol was used: initial denaturation step at 95  °C for 
2 min then 40 cycles of 95 °C for 10 s and 60 °C for 40 s. 
Specificity of the qPCR amplification was confirmed by the 
sequencing of obtained DNA fragments (data not shown).
Standard curves prepared with different amounts of 
qPlasmid (40, 4 × 102, 4 × 104, 4 × 106 and 4 × 108 cop-
ies) were used to determine the number of copies in the 
samples using a linear regression model. All analyses 
were performed in triplicates.
Determination of total chromosome copies (qControl 
amplicons), excised SCCmec (qEx amplicons) 
and circularized SCCmec (qCirc amplicons)
Genomic DNA samples were quantified using NanoDrop 
ND-1000 (Thermo Fisher Scientific AG) and diluted in 
nuclease-free H2O at a concentration of 10 ng/μL. A total 
of 10 ng was used for the qPCR assay. Quantification of 
qControl, qEx and qCirc amplicons was done by extrapo-
lating the results from the standard curve obtained in the 
standardization experiments (see above), using the fol-
lowing formula:
 where Ct is the threshold cycle; a and b are the slope 
and the y-intercept of the standard curve, respectively. 
The dynamic range of the assay ranged from 4 × 108 to 
40 amplicon copies. Proportions of excisants and cir-
cular form of SCCmec were calculated by dividing the 
absolute amount of the qEx and qCirc amplicons by the 
absolute amount of qControl amplicons. Negative con-
trols consisting in nuclease-free H2O were included in 
the analysis.
Statistical analysis
Unpaired t test was used to assess statistical differences 
between excision frequencies of cultures with different 
inocula (1/100 and 1/10,000). A p value of <0.05 was con-
sidered to indicate statistical significance.
Sample copy number = 10
((
Ctsample−b
)
/a
)
Fig. 1 Schematic representation of SCCmec excision and formation of its circular form. The figure shows the linear SCCmec integrated in the 
chromosome (a), the circularized SCCmec excised from the chromosome (b) and the religated chromosome after excision (c). Chromosomal 
DNA is shown in yellow and SCCmec DNA is shown in dark blue. Locations of primers used for qPCR are shown by arrows and their amplicons are 
highlighted in light blue. qControl amplicon is used to determine the number of chromosomes in the assay, while qEx and qCirc specifically detect 
excisants and circularized SCCmec, respectively
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Results
Rate of SCCmec excision in standard experimental 
conditions
Quantitative PCR was used to measure the amounts of 
both unoccupied chromosomal sites and SCCmec circu-
lar forms by specific amplification of the reconstituted 
chromosomal insertion site obtained after SCCmec exci-
sion and the junction formed upon SCCmec circulariza-
tion, respectively (Fig.  1). These were compared to the 
total number of chromosomes, which was determined 
by targeting a region of the rlmH gene, present in both 
MRSA- and MSSA-like cells (Fig. 1).
Prior to the quantification of net excision rates, it was 
critical to ensure that the parent MRSA N315 and its 
excised mutant N315EX grew at the same rate in our 
experimental conditions. Any growth advantage of one of 
the strains would bias the results, since that strain would 
become overrepresented in the culture over time. Thus, 
a co-culturing assay in which 102 CFU/mL of N315 and 
N315EX were inoculated together in 10 mL TSB was per-
formed. Both strains grew at the same rate and did not 
interfere with each other for up to 72 h (Additional file 1: 
Supporting data 2).
The ratio of excised forms versus total chromosomes 
was first measured during growth at 37  °C in TSB. 
Figure  2 indicates that this ratio was approximately 
2  ×  10−6 already at first time point of the culture (i.e. 
3 h), and remained constant in spite of further bacterial 
multiplication. However, our results also show that an 
overnight culture of N315 contains ca. 103/mL excisants. 
In fact, such culture contains ca. 2 × 109/ml cells and the 
frequency of excisants is 2 × 10−6/mL (Fig. 2). Knowing 
this, we noticed that when we were using a 1/100 dilution 
of an overnight culture as inoculum, 10 excisants/mL (i.e. 
MSSA cells) were readily introduced at beginning of the 
experiment. Therefore, our observations might result 
only from multiplication of the pre-introduced excisants. 
To answer this question, we performed the same experi-
ment, except that we used a 1/10,000 dilution of an 
overnight culture as starting inocula. This ensured a the-
oretic carryover of less than one excisant (0.1 excisants/
mL), in opposition to 10 excisants/mL inoculated with 
the 1/100 dilution. Figure  3 (grey columns) shows that 
a constant ratio of approximately 8  ×  10−7 excisants 
was again present throughout the experiment, which 
could not result from carryover, indicating that excision 
occurred de novo. The significantly higher frequency of 
excisants observed for the 1/100 dilution inocula could 
be explained by the presence of the carryover from over-
night cultures in addition to newly excised cells (Fig. 3). 
To confirm our results, we tested the contribution of de 
novo excision to the total number or excisants in cultures 
undergoing successive passages. We reasoned that if de 
novo excision occurred in addition to carry over in new 
cultures, then repeating successive cultures should dem-
onstrate a progressive accumulation of excisants, result-
ing from the sum of carry over plus de novo excisions. In 
contrast, if carry-over was the only source of excisants for 
new cultures, the frequency of 2 × 10−6 excisants should 
remain stable over time. A 1/100 dilution (i.e. 0.1 mL in 
10  mL) from an overnight culture containing 109 CFU/
mL was inoculated into fresh broth, which was left to 
grow to the stationary phase (Fig.  4a). The new culture 
was grown to the stationary phase and used to reinocu-
late the next fresh culture, and the process was repeated 
for 9 consecutive passages. Figure 4b shows that the ratio 
of excised forms to total chromosomes increased approx-
imately 10 times over the whole experiment. Thus, each 
of the 9 passages had contributed for an increase of a lit-
tle more than 10−6 de novo excisants, which summed up 
to a tenfold increase in excisants (i.e. approximately 10−5 
instead 10−6) at the end of the experiment. This experi-
ment was also performed using 1/10,000 dilutions as 
inocula for consecutive cultures (Fig. 4a). The increase in 
excisant frequency was less pronounced and results were 
not significant as in the case of the 1/100 dilution.
Detection of the circular form of SCCmec and effect 
of oxacillin treatment
In addition to the occupancy of the SCCmec insertion 
site, our study aimed at detecting the SCCmec circular 
form created upon excision. Extrachromosomal SCC-
mec cannot replicate autonomously and must be con-
stantly generated de novo in order to be detectable. Using 
our experimental settings, quantification of the circular 
form remained below the limit of detection during all 
Fig. 2 Growth curve and frequency of excisants in MRSA N315 
grown in TSB. Bacteria were grown at 37 °C as described (closed 
diamonds) and sampled after 3, 24 and 72 h for DNA extraction and 
qPCR analysis. The open columns represent the ratio of excised versus 
chromosomes copies at each sampling time. Error bars represent the 
average ± SD of three independent measurements performed in 
three independent cultures
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time-points. On the other hand, using endpoint PCR (40 
cycles) with an excess of DNA template (approximately 
0.5 µg), the specific junction formed upon SCCmec circu-
larization could be detected at 3 h. Similar intensities of 
the bands suggested that approximately the same amount 
of PCR product was present at 24 h and 72 h, corroborat-
ing our hypothesis excision of SCCmec might take place 
only during the early stages of bacterial growth.
This hypothesis was further supported by the results 
obtained with oxacillin treatment. We reasoned that if 
excision occurred only transiently at the beginning of 
incubation and did not occur later in growth, then the 
oxacillin-susceptible excisants should be inhibited and 
become diluted off along growth. In contrast, if excisants 
would continuously arise at a sizeable rate (e.g. 2 × 10−6) 
from SCCmec-positive cells growing in oxacillin, then 
molecular signatures of de novo excised chromosomes 
should be detectable even if the resulting methicillin-
susceptible excisants could not grow. Figure 3 shows that 
excisants rapidly disappeared after addition of oxacillin 
and that no detectable excision occurred thereafter. This 
supports the hypothesis that excision occurred tran-
siently at the beginning of growth.
Discussion
In the present study, we developed a qPCR-based 
method to monitor the rate of net excision of SCCmec 
in MRSA, taking strain N315 as model system. We found 
that in standard conditions, i.e. growth at 37  °C in TSB, 
the ratio of excised versus total chromosomes in N315 
was approximately 2  ×  10−6. This observation suggests 
that, in our experimental conditions, a culture of N315 
is composed of a mixture of a majority of cells carrying 
SCCmec and of rare cells without it. This proportion was 
Fig. 3 Determination of rates of excisants and presence of circular forms of SCCmec during growth of MRSA N315 various growth conditions. a In a 
first series of experiments, bacteria were grown at 37 °C in TSB (continuous line), but inoculated with either a 1/100 or a 1/10,000 dilutions of an over-
night culture. Open columns represent the rates of excisants following inoculation with the 1/100 dilution and grey columns represent the rates of 
excisants following inoculation with the 1/10,000 dilution. In a second series of experiments oxacillin (final concentration of 4 mg/L) was added at 
the time of inoculation and both growth (dotted line) and rates of excisants (black column) were followed over time. Asterisks indicate that measure-
ments were below the limit of detection. Error bars represent the average ± SD of three independent measurements performed in three independ-
ent cultures. b Presence of closed circular SCCmec during growth in TSB was detected by endpoint PCR using 200 or 500 ng of DNA previously used 
as template for qPCR. Circular SCCmec could not be quantified by qPCR because it remained below detection limits
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already present at the first checkpoint during growth, i.e. 
3 h after inoculation, and remained constant until 72 h in 
the late stationary growth phase. The consecutive passage 
experiments further supported the finding that in the 
present experimental conditions, net excision occurred 
de novo at the rate of approximately 2 × 10−6. By diluting 
the inocula to 1/10,000, we excluded the possibility that 
detected excisants were due to carry-over from preced-
ing cultures. We did observe that the excisants accumu-
lated more slowly in the experiment with high 1/10,000 
dilution, confirming that the frequency of excisants is the 
outcome of de novo excision and carry-over.
Net production of excisants in the presence of oxacil-
lin was detected only during the early stages of growth, 
since the antibiotic was inhibiting the replication of bac-
teria without SCCmec, as expected. Several studies have 
assessed the expression of ccrAB genes in the presence 
of β-lactams [14, 16]. However, it is difficult to compare 
these results with our observations. First, our experiment 
measure net excision, and it is a net product of molecu-
lar process of excision and reinsertion, both depending 
on the activity of CcrAB recombinases. Moreover, the 
knowledge of post-transcriptional and post-translational 
regulation of CcrAB recombinases is quite limited. Nev-
ertheless, differential expression of ccrAB genes between 
different MRSA strains could suggest that SCCmec exci-
sion might vary between different cassette types and 
MRSA backgrounds. Moreover, nucleotide variations in 
ccrAB genes from different SCCmec have been shown to 
influence the recombination activity and might influence 
the rates of excision as well [17]. Variation in the excision 
of SCCmec might be also observed in different ecologi-
cal niches, as in the case of hospital-acquired MRSA and 
community-acquired MRSA, especially due to different 
antibiotic pressures. In the case of community-acquired 
MRSA, the smaller size of SCCmec might represent a fac-
tor facilitating the excision.
With our approach we measured net excision rates, and 
we could not directly determine how much actual exci-
sion and reinsertion occurred. However, the inability to 
detect the extrachromosomal circular form of SCCmec 
at all time-points suggested that excision might take 
place punctually during the early stages of growth. The 
consecutive passage experiments indicated that SCC-
mec is lost from cells during several cycles of replication, 
a situation that could theoretically lead to the fade of a 
given MRSA population. However, our experiment sug-
gested several reasons why this may never happen. The 
most obvious is the selection pressure for maintenance 
of SCCmec and against excisants by antibiotics. Moreo-
ver, our experiments suggested that the excision hap-
pens mostly during the early growth of bacterial cells. 
The excision rate is likely much lower among MRSA 
colonizing human hosts, where the growth rates are cer-
tainly much slower. Additionally, because of their low fre-
quency, the excisants might simply be extremely diluted 
or even lost during consecutive passages, e.g. from one 
human host to another, as suggested by the experiment 
with high 1/10,000 dilution, where the excisants accumu-
lated more slowly than 1/100 dilution. These preliminary 
observations give important clues about the mobilization 
of SCCmec, a poorly understood process.
Conclusions
Taken together, the present results indicate that excision 
of SCCmec occurred at a rate of approximately 2 × 10−6 
in MRSA N315. This observation is concordant with a 
previous study in which the excision rate was evaluated 
to be lower than 10−4 [10]. The dynamics of the pro-
portion of excisants during growth suggests that exci-
sion occurred rather early on, at a given cell density, and 
Fig. 4 Determination of rates of excisants during serial subcultur-
ing of MRSA N315. a An overnight culture grown in TSB at 37 °C was 
used to inoculate a fresh 10 mL TSB culture with dilutions of 1/100 
or 1/10,000. The new culture was allowed to grow overnight and 
used to reinoculate a new fresh culture, and this was repeated for 9 
passages. DNA extractions and qPCR were performed at cycles 1, 5 
and 9 as indicated. b Variation of the frequency of excisants over the 
passages. Error bars represent the average ± SD of three independent 
measurements performed in three independent cultures. Statistical 
differences were assessed by the unpaired t test and asterisks repre-
sent statistically significative results (p < 0.05)
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during a limited period of time. The technique described 
here for MRSA N315 is amenable to study excision of 
other types of SCCmec cassettes in other MRSA back-
grounds, in order to better understand this crucial step of 
the horizontal transfer of this mobile element.
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